ArticleJournal of pain and symptom management2020
Availability of Internationally Controlled Essential Medicines in the COVID-19 Pandemic.
Article in Journal of pain and symptom management, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 59 citations in OpenAlex.
- Hospice referral patterns in India during COVID-19: A retrospective study on advanced cancer patients.BMC palliative care · 2026Article
- Measuring palliative care integration in Malawi through service provision, access, and training indicators: the Waterloo Coalition Initiative.BMC palliative care · 2024Article
- Impact of the COVID-19 Pandemic on Medical Product Procurement, Prices, and Supply Chain in Zimbabwe: Lessons for Supply Chain Resiliency.Global health, science and practice · 2023Article
- Pandemic treaty should include provisions for palliative care.Bulletin of the World Health Organization · 2023Article
- Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesia.Journal of pharmaceutical policy and practice · 2023Article
- Analgosedation in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation Support.ASAIO journal (American Society for Artificial Internal Organs : 1992) · 2022Review
- Can You Hear Us Now? Equity in Global Advocacy for Palliative Care.Journal of pain and symptom management · 2022Article
- The COVID-19 Pandemic: Early Ripple Effects in Pediatric Palliative Care.Children (Basel, Switzerland) · 2022Review
- Pharmacists and opioid use disorder care during COVID-19: Call for action.Journal of the American College of Clinical Pharmacy : JACCP · 2022Article
- National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project.BMC palliative care · 2022Article
- Changes in Purchases for Intensive Care Medicines During the COVID-19 Pandemic: A Global Time Series Study.Chest · 2021Article
- Top Ten Tips Palliative Clinicians Should Know About Evidence-Based Advocacy.Journal of palliative medicine · 2021Article
- COVID-19: Pain Management in Patients with SARS-CoV-2 Infection-Molecular Mechanisms, Challenges, and Perspectives.Brain sciences · 2020Article
- Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorder.Substance abuse · 2020Article
- Impact of COVID-19 pandemic on community medication dispensing: a national cohort analysis in Wales, UK.International journal of population data science · 2020Observational
- Article
- American Academy of Nursing Expert Panel consensus statement on nursing's roles in ensuring universal palliative care access.Nursing outlookArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Section 2 of the 2019 World Health Organization Model List of Essential Medicines includes opioid analgesics formulations commonly used for the control of pain and respiratory distress, as well as sedative and anxiolytic substances such as midazolam and diazepam. These medicines, essential to palliative care, are regulated under the international drug control conventions overseen by United Nations specialized agencies and treaty bodies and under national drug control laws. Those national laws and regulations directly affect bedside availability of Internationally Controlled Essential Medicines (ICEMs). The complex interaction between national regulatory systems and global supply chains (now impacted by COVID-19 pandemic) directly affects bedside availability of ICEMs and patient care. Despite decades of global civil society advocacy in the United Nations system, ICEMs have remained chronically unavailable, inaccessible, and unaffordable in low- and-middle-income countries, and there are recent reports of shortages in high-income countries as well. The most prevalent symptoms in COVID-19 are breathlessness, cough, drowsiness, anxiety, agitation, and delirium. Frequently used medicines include opioids such as morphine or fentanyl and midazolam, all of them listed as ICEMs. This paper describes the issues related to the lack of availability and limited access to ICEMs during the COVID-19 pandemic in both intensive and palliative care patients in countries of all income levels and makes recommendations for improving access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.